Applications focused on LC/TOF from Waters - page 1
Open paper sgRNA AND mRNA SEQUENCE MAPPING VIA ENDONUCLEASE DIGESTION AND LC-MS ANALYSIS, USING NOVEL INFORMATICS WORKFLOWS
sgRNA AND mRNA SEQUENCE MAPPING VIA ENDONUCLEASE DIGESTION AND LC-MS ANALYSIS, USING NOVEL INFORMATICS WORKFLOWS
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper MAP SEQUENCE - A NOVEL SOFTWARE APP FOR RAPID AND AUTOMATED SEQUENCE MAPPING OF mRNA MOLECULES
MAP SEQUENCE - A NOVEL SOFTWARE APP FOR RAPID AND AUTOMATED SEQUENCE MAPPING OF mRNA MOLECULES
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
Walk-up Mass Confirmation of Glucagon-like Peptides (GLP-1) Using the Xevo™ G3 QTof Combined with RemoteAnalyzer® Open Access Software
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
Characterizing “nature’s Ozempic ”: Non-targeted screening of berberine supplements using ion mobility high-resolution mass spectrometry
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Elucidating the Fine Structure of Fructan Isomers in Agave using Cyclic Ion Mobility Mass Spectrometry
Elucidating the Fine Structure of Fructan Isomers in Agave using Cyclic Ion Mobility Mass Spectrometry
Ion Mobility, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
Ion Mobility, LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Food & Agriculture
Open paper Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
Multipass Ion Mobility Separation of GLP-1 Receptor Agonist Impurities Using the SELECT SERIES™ Cyclic™ IMS
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
Investigating the Strength of the Sense and Antisense Oligonucleotide Interaction to Form siRNA Duplexes Using the BioAccord™ LC-MS System
LC/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC-MS Analysis of Two mRNA Critical Quality Attributes: 5’-Capping Efficiency and Average Poly(A) Tail Length and Heterogeneity Using the Xevo™ MRT Mass Spectrometer
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, Software
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
Head to Tail Analysis of mRNA by RapiZyme™ MC1 and Cusativin
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Pharma & Biopharma
Open paper Targeted and Non-Targeted Screening of Persistent Organic Pollutants (POPs) in Groundwater and Trade Effluent Wastewater Using the Xevo™ G3 QTof Mass Spectrometer
Targeted and Non-Targeted Screening of Persistent Organic Pollutants (POPs) in Groundwater and Trade Effluent Wastewater Using the Xevo™ G3 QTof Mass Spectrometer
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental
